Physician profile
Luz Kelly
NPI 1164154803
$1,025.95
in general payments reported to CMS, 2019-2025
12 companies · $507 in 2025
The $507 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $519 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,025.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $276.46 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $149.83 | 2024-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Exact Sciences Corporation | $134.88 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $114.74 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $114.49 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Renalytix Ai, INC. | $67.45 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Dexcom, INC. | $53.96 | 2024-2025 | Dexcom G6 Transmitter |
| Edwards Lifesciences Corporation | $30.18 | 2025 | Sapien 3 Ultra Resilia |
| Seqirus USA INC | $30.01 | 2024 | Fluad, Flucelvax |
| Phathom Pharmaceuticals, INC. | $26.28 | 2024 | Voquezna |
| Abbvie INC. | $13.98 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.69 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luz Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.